Dymista vs Qnasl

Listen to the article instead of reading through it.

0:00

Introduction

For patients suffering from allergic rhinitis or other forms of nasal allergies, certain medications that can help alleviate symptoms by blocking the effects of histamines and reducing inflammation in the nasal passages are crucial. Dymista and Qnasl are two such drugs often prescribed for these conditions. Both have an effect on reducing inflammation but they act through different mechanisms. Dymista is a combination nasal spray containing azelastine (an antihistamine) and fluticasone propionate (a corticosteroid), which helps not only to block the action of histamines but also reduce swelling and inflammation in the nose. On the other hand, Qnasl is a corticosteroid-based drug that primarily works by decreasing inflammation, thereby relieving symptoms like runny or stuffy nose, itching, sneezing, etc.

What is Dymista?

Dymista and Qnasl are both nasal sprays that belong to a class of medications known as corticosteroids. They offer relief for individuals suffering from allergic rhinitis, often characterized by symptoms such as a runny nose, sneezing, and itching. Dymista is unique in its formulation by combining two active ingredients: azelastine hydrochloride (an antihistamine) and fluticasone propionate (a corticosteroid). This dual-action approach not only reduces inflammation but also blocks the effects of histamines which cause allergy symptoms.

Qnasl, on the other hand, contains beclomethasone dipropionate as its sole active ingredient. It primarily works by reducing swelling in the nasal passageways making it easier to breathe. Both Dymista and Qnasl require prescriptions and are FDA approved; however, their usage patterns differ due to their compositions which influence side effect profiles with considerations specific to each patient's condition.

What conditions is Dymista approved to treat?

Dymista is approved for the treatment of different conditions:

Seasonal and perennial allergic rhinitis in patients 6 years of age and older
Nasal symptoms associated with seasonal allergies in adults and children ages 12 years and older

Meanwhile, Qnasl is used to treat:

Symptoms of year-round (perennial) allergies in adults and children who are at least 4 years old
Symptoms of seasonal allergies in adults and children who are at least 2 years old.

How does Dymista help with these illnesses?

Dymista helps to manage symptoms of seasonal allergies by combining both an antihistamine and a corticosteroid. The antihistamine, azelastine, works by blocking the effects of histamines which are produced during allergic reactions. Histamines trigger itching, sneezing, runny nose and watery eyes. The corticosteroid component, fluticasone propionate, reduces inflammation and swelling in the nasal passages.

Qnasl (beclomethasone) on the other hand is purely a corticosteroid that reduces inflammation within the nasal passage. It does not contain an antihistamine like Dymista does.

Both medications play vital roles in allergy management but through different mechanisms; Dymista targets both inflammation and histamine while Qnasl primarily focuses on reducing inflammation.

What is Qnasl?

Qnasl is a brand name for beclomethasone, which is a corticosteroid. It works by reducing inflammation in the nasal passages and was first approved by the FDA in 2012. Beclomethasone does not inhibit any histamine or leukotriene pathways, meaning its mechanism of action is slightly different than that of other antihistamines such as Dymista. Its primary focus on inflammation means that side effects related to drowsiness or dry mouth are less common with Qnasl compared to traditional antihistamines like Dymista. The anti-inflammatory properties can also be beneficial for those suffering from chronic sinusitis and seasonal allergies who don't respond well to typical antihistamines.

What conditions is Qnasl approved to treat?

Qnasl is a corticosteroid nasal spray that has been approved by the FDA for:

The treatment of seasonal and perennial allergic rhinitis in adults and adolescents aged 12 years and older
The relief of nasal congestion associated with seasonal allergic rhinitis (hay fever) in patients aged 12 years or older.

How does Qnasl help with these illnesses?

Corticosteroids, like the beclomethasone in Qnasl, are potent anti-inflammatory agents that reduce swelling and inflammation in the nasal passages. They work by decreasing the production of inflammatory substances triggered by an allergen. As with antihistamines, a reduction in inflammation can alleviate many symptoms of allergic reactions such as runny nose, itching or sneezing. Qnasl's unique action on these inflammatory substances may provide more comprehensive symptom relief for patients suffering from seasonal or perennial allergies. Unlike Dymista which combines an antihistamine and a steroid, Qnasl contains only a corticosteroid making it potentially a better option for those who do not respond well to combined therapies or have contraindications to antihistamines.

How effective are both Dymista and Qnasl?

Both Dymista and Qnasl are effective nasal sprays for treating symptoms of allergic rhinitis, with each having been approved by the FDA within a few years of each other. They work in different ways to achieve their effects: Dymista is a combination of an antihistamine (Azelastine) and a corticosteroid (Fluticasone propionate), while Qnasl (beclomethasone dipropionate) is purely a corticosteroid.

Their effectiveness was directly studied in various clinical trials; both showed significant efficacy in managing allergy symptoms such as sneezing, itching, runny nose, and congestion. In these studies, no major differences were observed between patients receiving Dymista or those getting Qnasl on several metrics used to assess treatment success for allergic rhinitis.

Dymista seems to start alleviating allergy symptoms quickly upon usage due to its dual action formula. Both ingredients contribute towards reducing inflammation as well as blocking histamine receptors which play a key role in triggering allergy symptoms. The typical dose believed to show optimal efficacy is one spray per nostril twice daily.

Qnasl has shown promising results against placebo in treating allergies and also shows similarity in efficacy with many common antihistamines/corticosteroids combinations. However, it's typically considered after trying first-line treatments like oral antihistamines or intranasal steroids alone because it doesn't have the additional benefit of an antihistamine unlike combo drugs like Dymista.

abstract image of a researcher studying a bottle of drug.

At what dose is Dymista typically prescribed?

Dymista is generally administered as one spray in each nostril twice daily for individuals aged 12 years and older. For children between the ages of 6-11, it's usually one spray in each nostril once daily. Qnasl, on the other hand, is typically used as two sprays in each nostril once daily for adults and adolescents over 12 years old. Children aged 4 to 11 are usually prescribed a single spray per nostril once per day. As with any medication, dosage can be adjusted based on individual response after initial use. It should be noted that exceeding recommended doses without medical advice may lead to unwanted side effects.

Find Top Clinical Trials

Choose from over 30,000 active clinical trials.

At what dose is Qnasl typically prescribed?

Qnasl treatment is usually initiated at a dosage of two sprays in each nostril once daily, which equates to 320 mcg/day. If needed, the dose can be increased to four sprays in each nostril daily (640 mcg/day), divided into two doses, with approximately 12 hours between administrations. The maximum dosage recommended for adults is four sprays per nostril per day and for children aged 4 to 11 years old it's one spray per nostril daily. Always follow your healthcare provider's instructions on usage and if there is no response or an inadequate response after a few weeks, consult your doctor as further evaluation may be required.

What are the most common side effects for Dymista?

Possible side effects of Dymista may include:

Changes in taste
Nosebleeds
Headache
Itching or rash
Cough, throat irritation or hoarseness
Nausea
Fatigue (general weakness and tiredness)
Weight gain

In comparison, some common side effects associated with Qnasl are:

Nasal discomfort including dryness or burning/stinging sensation
Bloody nose/nose bleeds
Sneezing attacks
Headaches
Sore throat

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

abstract image of a patient experiencing side effect

Are there any potential serious side effects for Dymista?

Rare but serious side effects of Dymista and Qnasl could include:

Signs of allergic reaction: hives, difficult breathing, swelling in your face or throat
Nasal sores or white patches inside or around your nose
Blurred vision, tunnel vision, eye pain or swelling, seeing halos around lights; these may be signs of glaucoma
Fast heartbeats, shortness of breath (especially during sleep), irregular heartbeat
Severe drowsiness causing you to feel like you might pass out.

If you experience any symptoms related to adrenal insufficiency such as severe weakness/lethargy, weight loss/increased hunger/thirst leading to frequent urination - seek medical help immediately.

While using either medication ensure regular monitoring for changes in vision and maintaining good nasal hygiene can prevent most complications. Should any adverse symptom occur discontinue use and consult with a healthcare professional promptly.

What are the most common side effects for Qnasl?

While Dymista offers relief for certain nasal symptoms, Qnasl may cause its own set of side effects. These include:

Dry or irritated throat
Nasal discomfort, bleeding or ulcers
Headache
Unpleasant taste in the mouth
Cough
Sneezing after use

Note that while these are common reactions to Qnasl, not every individual will experience them and they often decrease over time as your body adjusts to the medication. However, if any of these persist or worsen, it's recommended you consult with a healthcare provider promptly.

Are there any potential serious side effects for Qnasl?

While Qnasl is generally safe for most patients, it can potentially cause some serious side effects in rare cases. Watch out for these symptoms:

Signs of an allergic reaction such as hives; difficulty breathing; swelling of your face, lips, tongue, or throat
Vision problems or eye pain
Severe nosebleeds
Wheezing, chest tightness, trouble breathing
White patches or sores inside your nose that won't heal
Feeling very thirsty or hot
Being unable to urinate

If you experience any of these symptoms after using Qnasl, stop using the medication and immediately seek medical help. Always remember to use medications as prescribed by healthcare professionals and inform them about any other medicines you are currently taking.

Contraindications for Dymista and Qnasl?

Both Dymista and Qnasl, like most other nasal sprays, may cause specific side effects. If you notice symptoms such as severe or ongoing nosebleeds, noisy breathing, runny nose or crusting around your nostrils feel worse than before the medication was started, consult with your healthcare provider immediately.

Neither Dymista nor Qnasl should be taken if you are taking certain medications for fungal infections (such as ketoconazole) or HIV/AIDS (such as ritonavir). Always inform your physician about all the medications you are currently taking; some drugs will require a period of clearance from your system to prevent dangerous interactions with Dymista and Qnasl.

Furthermore, both these nasal sprays contain steroids which can weaken your immune system making it easier for you to get an infection. They can also slow growth in children so regular check-ups are recommended when using this medicine. Always use the medicine exactly as directed and do not share it even if someone else has similar symptoms.

How much do Dymista and Qnasl cost?

For the brand name versions of these nasal sprays:

The price for Dymista (a 23g spray) averages around $230, which works out to approximately $7.60 per day for a typical dosage (1 spray in each nostril twice daily).
The cost for Qnasl is about $200 for a standard size canister, which can last up to 30 days depending on usage. This translates to roughly $6.66 per day if used as directed (2 sprays in each nostril once daily).

Thus, if you use the standard dosages of both products, then brand-name Qnasl is less expensive on a per-day treatment basis than Dymista.

Please note that the cost should not be your primary consideration when determining which of these drugs is right for you; it's more important to consider their effectiveness and potential side effects under guidance from healthcare professionals.

As of now, there are no generic versions available either for Dymista or Qnasl so costs remain significant across the board.

Popularity of Dymista and Qnasl

Dymista, which includes the active ingredients azelastine and fluticasone, was prescribed to roughly 1.2 million people in the US in 2020. This combination nasal spray accounted for just under 3% of all prescriptions within its drug class (nasal corticosteroids). Its prevalence has seen a steady increase since it was approved by FDA in 2012.

Qnasl (beclomethasone) on the other hand, is also used as a treatment for nasal symptoms caused by allergies. In comparison to Dymista, Qnasl saw slightly fewer prescriptions with approximately one million people receiving this medication in the US throughout 2020. Accounting for about 2.5% of total nasal corticosteroid prescriptions, Qnasl's usage has been relatively steady over recent years.

Conclusion

Both Dymista (a combination of azelastine and fluticasone) and Qnasl (beclomethasone) demonstrate efficacy in managing symptoms related to allergies, supported by various clinical studies indicating that they are more effective than placebo treatments. In some cases, the drugs may be used together but this is subject to careful consideration by a healthcare provider due to potential interactions. Their mechanisms of action differ: while both have a corticosteroid component that reduces inflammation, Dymista also contains an antihistamine which further helps control allergy symptoms.

Dymista is often considered as a first-line treatment option because it tackles two major causes of allergic reactions with its dual-action formula. However, Qnasl can be an excellent choice for patients who only require the anti-inflammatory effect or cannot tolerate antihistamines.

Both medications are available in generic form providing significant cost savings especially for patients who must pay out-of-pocket. With either medication, you might not notice immediate relief from your allergy symptoms as it sometimes takes several days before their full effect becomes apparent.

The side effects profile between these two drugs is similar; generally well-tolerated with common side effects such as headache and nosebleeds being shared among them. However, Dymista carries additional risk factors associated with antihistamines like drowsiness or bitter taste in mouth due to its combined formulation. For both drugs, if you experience any severe reactions such as difficulty breathing or swelling in your face or throat seek medical help immediately.